@imdavelee's TRT optimization claims need context

What does this video actually claim?

Dave Lee suggests men feel best with free testosterone between 500-1500 pmol/L, well above standard reference ranges. He argues providers who won't adjust doses beyond normal ranges show red flags, and that symptoms matter more than lab values for TRT optimization.

The post promotes his TRT Masterclass and positions lab reference ranges as obstacles to proper hormone optimization. Lee frames this as patient advocacy against overly conservative medical approaches.

What do the reference ranges actually represent?

Most labs define normal free testosterone as 225-720 pmol/L for men aged 20-50. Lee's suggested range starts within normal limits but extends more than double the upper boundary.

These reference ranges come from population studies of healthy men. The Testosterone Trials (Snyder et al., NEJM, 2016) used 300 ng/dL total testosterone as their threshold for hypogonadism, roughly equivalent to 450 pmol/L free testosterone.

Reference ranges aren't arbitrary. They reflect the 95% confidence interval for healthy populations, meaning 95% of normal men fall within these bounds.

Does higher testosterone always mean better outcomes?

The evidence doesn't support a linear relationship between testosterone levels and wellbeing above normal ranges. The Testosterone Trials found benefits for men with confirmed hypogonadism, but participants were only treated to mid-normal levels.

A 2020 systematic review (Corona et al., Andrology) found optimal benefits occurred when total testosterone reached 400-500 ng/dL, not supraphysiological levels. Higher doses increase risks without clear additional benefits.

Lee's upper limit of 1500 pmol/L approaches levels seen with anabolic steroid use rather than therapeutic replacement. At these concentrations, men face increased risks of erythrocytosis, sleep apnea, and cardiovascular events.

Why might providers hesitate to exceed normal ranges?

Medical providers follow evidence-based guidelines, not patient preferences alone. The Endocrine Society's 2018 clinical practice guidelines recommend targeting mid-normal testosterone levels to balance benefits and risks.

Supraphysiological testosterone levels can suppress natural hormone production permanently. They also increase hematocrit levels, sometimes requiring therapeutic phlebotomy to prevent blood clots.

Insurance coverage typically requires documented hypogonadism and symptoms. Providers who routinely prescribe testosterone for optimization rather than replacement face regulatory scrutiny and liability concerns.

What should patients actually know about TRT dosing?

Legitimate TRT aims to restore normal testosterone levels in men with confirmed hypogonadism, not to optimize performance in healthy individuals. Symptoms should guide treatment, but within the context of appropriate hormone levels.

Men considering TRT should undergo comprehensive evaluation including morning testosterone measurements, luteinizing hormone levels, and assessment for secondary causes of low testosterone. This workup often reveals treatable underlying conditions.

Testosterone replacement remains a medical treatment with real risks and benefits. The goal isn't maximizing hormone levels but restoring normal physiology in men with documented deficiency.